Q: I'm confused with your explanation on this arrangement. Please help me understand how many ACB shares I would get under the following two 20 Day VWAP scenarios:
If the VWAP is $10, how many would I get?
If the VWAP is $15, how many would I get?
Thanks as always for your amazing service!
Q: What do you think of this cannabis company in the US? Experienced board members. Same space as Alcann (cliq) in Canada. Issuing stock to buy pharma company. Touted as the apple of weed.
Value your opinion.
Q: I know you have reservations about the company's history and certain individuals, but momentum has been good recently. On Oct. 17 at midday, about 120,000 shares ($1 million) traded in a few minutes, which I assume was an institutional order. Total volume for the day was near 600,000 shares, which has only occurred a few other times earlier this year, when the share price was much lower. Are you aware of any increasing institutional interest in VMD?
Q: What did you think of Aphria's earnings? Looks like they delivered eps of 9 cents a share when $0.00 was expected. Thompson Reuters has their current fiscal year (2019) estimates at 14 cents. Looks like a muted outlook considering what I thought was a pretty decent Q1.
Q: Not sure if readers are aware, but it looks like Photon bought #650,000 of their own shares during September with their abundance of cash. Also, Mawer New Canada increased their position to over 4% of the company. Can you comment about these 2 developments?
Q: I owned ICC Labs which got a take over offer from Aurora to be paid in ACB shares. ACB price has gone crazy while ICC is still trading below the offer price. I must be missing something cos I cant figure out why everyone isn't buying ICC shares to give them up in exchange for ACB shares valued at the time of the deal. Thanks!
Q: Hi, I am looking for a company that is growing at +20%, has a P/E multiple of under 20 and pays a modest dividend. Aecon fits this but do you have better suggestion? I look for a 3 year timeline.
Q: Good Morning 5i
With Oct. 17th. approaching do you see "profit taking" hitting SP hard, followed by rise with news? Or steady price levels awaiting expected news of deployment of $5B of Constellation investment in the firm? Do you expect more institutional and fund ownership with legalization occurring. I am long holder atleast until end of 2019. Thanks for any insight you can offer.
Q: For lack of better words, many stocks are presently on sale OR are atleast much lower than we paid for them, sometimes by a huge (very huge) margin. Assuming these opportunities are real, it would be an ideal time to add a little.
My understanding of your assessment is that you have high hopes for this company, believe that nothing has changed other than unpredictable market forces.
The stock has really dropped, which does not imply a bargain if it is still overpriced; however, my understanding is that we liked the stock at $2.00 and nothing has changed, so I must believe that this a great buying opportunity as long as we continue to properly diversify and understand that this may take 5-10 years. Your thoughts on this as a buying opportunity? Any new input from their mgmt? Any concerns with cash burnout over time? Other than wishing there were more sales contracts (which is definitely key), any other issues?
I ask these questions because I feel that we like to jump on the bandwagon when it is moving uphill with great momentum but want to ignore it when it is unwanted, even though it is the same bandwagon (i.e. same fundamentals). As a general comment are we not following a herd mentality (which is not wrong in itself on many occassions)? Should we not be greedy (at times) when others are fearful? I know this these are hard, fundamental questions about investing but your thoughts are appreciated OR maybe this could be the theme of a future blog... (I think that these are opportune times to pick up shares in companies we like even though their momentum is negative, even though we are buying the dips, even though we are possibly doubling down...)
As an aside, this was recently published. I just saw it this morning.
https://patient-monitoring.healthcaretechoutlook.com/vendors/top-patient-monitoring-solution-providers-2018.html
Q: Good morning. Which stocks are most tempting to you this morning? Or, in your seasoned opinion does this sell off have more steam and maybe holding for a bit before buying might be best? Thanks!
Q: You mentioned earlier that with rate increases and other uncertainty growth stocks take a hit. Also, that there is some opportunity/interesting options out there. What would you recommended as a buy right now? (ps. I'm currently following the balanced growth portfolio.)
Q: Can you provide any insight into the acquisition announced yesterday?
What could it mean for the stock?
The terms sound too good to be true;
-to keep the asset acquisition cash-flow neutral to FLYHT during this period, PAC will pay FLYHT a subsidy of USD$3.3 million.
-Pursuant to the terms of the acquisition of PWS assets and the transition agreement, FLYHT is paying no monetary consideration to PAC for the PWS assets.